EQS-Adhoc: Ad-Hoc: Marinomed Biotech AG Intends to Proceed with Judicial Restructuring without Self-Administration 的 TOP News Austria - News From Austria and the Whole World
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Following the remedial procedure initiated in August 2024, Marinomed is now again required to apply for a judicial remedial procedure without self-administration. This is explained by the fact that the court-approved restructuring plan of 14 November 2024 cannot be fulfilled due to the termination of the negotiations by Unither Pharmaceuticals and the lack of earnout payments from Unither from the sale of the Carragelos business area and thus th…
EQS-Ad-hoc: Marinomed Biotech AG / Keyword(s): Insolvency Ad-hoc: Marinomed Biotech AG intends judicial recovery proceedings without self-administration 16.07.2026 / 23:10 CET/CEST Release of inside information pursuant to Article 17 of Regulation (EU) No 596/2014, transmitted by [1]EQS News – a service of the [2]EQS Group. The issuer is solely responsible for the content of this announcement. the issuer is solely responsible for the content of …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
